Skip to main content

Dr. Bassil I. Dahiyat

Equibles does not estimate personal net worth.

Get an email with a short summary when Xencor Inc publishes a filing, an earnings call transcript or a press release.

Get XNCR alerts

About Dr. Bassil I. Dahiyat

Dr. Bassil I. Dahiyat is recorded as Board Member and CEO at Xencor Inc (XNCR). The newest filing on record that lists Dr. Bassil I. Dahiyat as Board Member and CEO at Xencor Inc (XNCR) is dated April 27, 2026. The proxy statement of Xencor Inc reports total compensation of $5,521,205 for Dr. Bassil I. Dahiyat in fiscal 2025, including a base salary of $742,800. Disclosed compensation is on record for 6 fiscal years. Xencor Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Xencor Inc includes Bart Cornelissen (CFO), Bart Jan Cornelissen (CFO), Celia E. Eckert (General Counsel) and 7 others.

Affiliation history

  • Xencor Inc (XNCR)

    Board Member

    Proxy statement

    Current

    Start not stated–present

    Last confirmed April 27, 2026

  • Xencor Inc (XNCR)

    CEO

    Proxy statement

    Current

    Start not stated–present

    Last confirmed April 27, 2026

Company network

Current role

Biotechnology · Healthcare

Board Member, CEO

Leadership on record at Xencor Inc

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Xencor Inc (XNCR) $742,800 $5,521,205
2024 Xencor Inc (XNCR) $721,200 $6,811,829
2023 Xencor Inc (XNCR) $700,200 $7,965,955
2022 Xencor Inc (XNCR) $670,000 $7,705,952
2021 Xencor Inc (XNCR) $625,000 $5,370,295
2020 Xencor Inc (XNCR) $600,000 $4,480,925

Recent activity

No call appearances or filed executive changes recorded yet.